Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation

E. S. Christenson, B. Teply, V. Agrawal, P. Illei, A. Gurakar, J. A. Kanakry

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Primary effusion lymphoma is a rare subclass of non-Hodgkin lymphoma associated with human herpesvirus 8 infection and principally seen in human immunodeficiency virus-positive patients. We report on the case of a 72-year-old human immunodeficiency virus-negative male with a hepatic transplant 10 years prior, who presented with a symptomatic right-sided pleural effusion and was found to have primary effusion lymphoma by flow cytometric and cytopathologic examination. Immunohistochemistry of his lymphoma cells was positive for human herpesvirus 8. Both he and his donor had no identifiable risk factors for human herpesvirus 8 infection. The patient was intolerant of antiviral therapy and chemotherapy, dying 7 months after diagnosis. Posttransplant primary effusion lymphoma is exceedingly rare and carries a very poor prognosis. Individualized treatment strategies are necessary given the scant body of published literature with guidance based solely on case reports.

Original languageEnglish (US)
Pages (from-to)2762-2766
Number of pages5
JournalAmerican Journal of Transplantation
Volume15
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Primary Effusion Lymphoma
Human Herpesvirus 8
Liver Transplantation
Herpesviridae Infections
HIV
Pleural Effusion
Non-Hodgkin's Lymphoma
Antiviral Agents
Lymphoma
Immunohistochemistry
Tissue Donors
Transplants
Drug Therapy
Liver
Therapeutics

Keywords

  • Antibiotic: antiviral
  • cancer/malignancy/neoplasia: hematogenous/leukemia/lymphoma
  • complication: infectious
  • complication: malignant, infection and infectious agents
  • viral: human herpes virus 8 (HHV-8)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation. / Christenson, E. S.; Teply, B.; Agrawal, V.; Illei, P.; Gurakar, A.; Kanakry, J. A.

In: American Journal of Transplantation, Vol. 15, No. 10, 01.10.2015, p. 2762-2766.

Research output: Contribution to journalArticle

Christenson, ES, Teply, B, Agrawal, V, Illei, P, Gurakar, A & Kanakry, JA 2015, 'Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation', American Journal of Transplantation, vol. 15, no. 10, pp. 2762-2766. https://doi.org/10.1111/ajt.13321
Christenson, E. S. ; Teply, B. ; Agrawal, V. ; Illei, P. ; Gurakar, A. ; Kanakry, J. A. / Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation. In: American Journal of Transplantation. 2015 ; Vol. 15, No. 10. pp. 2762-2766.
@article{df9fccf249e54049b9e15089ea3d8616,
title = "Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation",
abstract = "Primary effusion lymphoma is a rare subclass of non-Hodgkin lymphoma associated with human herpesvirus 8 infection and principally seen in human immunodeficiency virus-positive patients. We report on the case of a 72-year-old human immunodeficiency virus-negative male with a hepatic transplant 10 years prior, who presented with a symptomatic right-sided pleural effusion and was found to have primary effusion lymphoma by flow cytometric and cytopathologic examination. Immunohistochemistry of his lymphoma cells was positive for human herpesvirus 8. Both he and his donor had no identifiable risk factors for human herpesvirus 8 infection. The patient was intolerant of antiviral therapy and chemotherapy, dying 7 months after diagnosis. Posttransplant primary effusion lymphoma is exceedingly rare and carries a very poor prognosis. Individualized treatment strategies are necessary given the scant body of published literature with guidance based solely on case reports.",
keywords = "Antibiotic: antiviral, cancer/malignancy/neoplasia: hematogenous/leukemia/lymphoma, complication: infectious, complication: malignant, infection and infectious agents, viral: human herpes virus 8 (HHV-8)",
author = "Christenson, {E. S.} and B. Teply and V. Agrawal and P. Illei and A. Gurakar and Kanakry, {J. A.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/ajt.13321",
language = "English (US)",
volume = "15",
pages = "2762--2766",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Human Herpesvirus 8-Related Primary Effusion Lymphoma after Liver Transplantation

AU - Christenson, E. S.

AU - Teply, B.

AU - Agrawal, V.

AU - Illei, P.

AU - Gurakar, A.

AU - Kanakry, J. A.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Primary effusion lymphoma is a rare subclass of non-Hodgkin lymphoma associated with human herpesvirus 8 infection and principally seen in human immunodeficiency virus-positive patients. We report on the case of a 72-year-old human immunodeficiency virus-negative male with a hepatic transplant 10 years prior, who presented with a symptomatic right-sided pleural effusion and was found to have primary effusion lymphoma by flow cytometric and cytopathologic examination. Immunohistochemistry of his lymphoma cells was positive for human herpesvirus 8. Both he and his donor had no identifiable risk factors for human herpesvirus 8 infection. The patient was intolerant of antiviral therapy and chemotherapy, dying 7 months after diagnosis. Posttransplant primary effusion lymphoma is exceedingly rare and carries a very poor prognosis. Individualized treatment strategies are necessary given the scant body of published literature with guidance based solely on case reports.

AB - Primary effusion lymphoma is a rare subclass of non-Hodgkin lymphoma associated with human herpesvirus 8 infection and principally seen in human immunodeficiency virus-positive patients. We report on the case of a 72-year-old human immunodeficiency virus-negative male with a hepatic transplant 10 years prior, who presented with a symptomatic right-sided pleural effusion and was found to have primary effusion lymphoma by flow cytometric and cytopathologic examination. Immunohistochemistry of his lymphoma cells was positive for human herpesvirus 8. Both he and his donor had no identifiable risk factors for human herpesvirus 8 infection. The patient was intolerant of antiviral therapy and chemotherapy, dying 7 months after diagnosis. Posttransplant primary effusion lymphoma is exceedingly rare and carries a very poor prognosis. Individualized treatment strategies are necessary given the scant body of published literature with guidance based solely on case reports.

KW - Antibiotic: antiviral

KW - cancer/malignancy/neoplasia: hematogenous/leukemia/lymphoma

KW - complication: infectious

KW - complication: malignant, infection and infectious agents

KW - viral: human herpes virus 8 (HHV-8)

UR - http://www.scopus.com/inward/record.url?scp=84941936883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941936883&partnerID=8YFLogxK

U2 - 10.1111/ajt.13321

DO - 10.1111/ajt.13321

M3 - Article

C2 - 25988353

AN - SCOPUS:84941936883

VL - 15

SP - 2762

EP - 2766

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 10

ER -